13F

Stock

Liminatus Pharma Inc.

Ticker not mapped · held by 15 managers

Reported value

$188.8K

Holders

15

+4 new · −2 exited

Holders’ est. mark

−$90.7K

Price effect on 9 books still in the name

Largest holder

$116.5K

Citadel

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Citadel677.5K$116.5K−$31.1KAdded$73.2K
GEODE CAPITAL MANAGEMENT, LLC117.8K$20.2K−$28.5KCut−$19.4K
JANE STREET GROUP, LLC71.3K$12.3KNew
UBS Group AG54.6K$9.39K−$8.49KCut−$2.44K
VANGUARD CAPITAL MANAGEMENT LLC50.4K$8.68KHeld
Vanguard Personalized Indexing Management, LLC34.7K$5.97KNew
VANGUARD FIDUCIARY TRUST CO23K$3.95KHeld
TWO SIGMA SECURITIES, LLC22K$3.79K−$5.2KCut−$3.46K
State Street19K$3.27K−$8.32KCut−$8.32K
BlackRock, Inc.13.3K$2.28K−$5.81KCut−$5.81K
Tower Research Capital LLC (TRC)7.57K$1.3K−$3.32KCut−$4.13K
CITIGROUP INC6.77K$1.16K−$1Added$1.16K
Cygnus Capital Advisors, LLC350K$60New
Virtu Financial LLC27.5K$5New
Farther Finance Advisors, LLC14$2−$7Cut−$17

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.